AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Ampio strengthens patent protection for Ampion with notice of allowance from patent office.

Europe Intelligence Wire

| March 21, 2012 | COPYRIGHT 2003 Financial Times Ltd. (Hide copyright information)Copyright

(From Pharma)

M2PHARMA-March 21, 2012-Ampio strengthens patent protection for Ampion with notice of allowance from patent office (C)2012 M2 COMMUNICATIONS http://www.m2.com

Biopharmaceutical company Ampio Pharmaceuticals Inc (Nasdaq: AMPE) said on Tuesday that it has received a notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion.

The company said that the allowed claims in this new patent protect pharmaceutical composition, includes the use of the low molecular weight fraction of commercially available (approved) human …

Related articles from newspapers, magazines, journals, and more
Cytos strengthens patent position of asthma drug candidate.
News wire article from: Europe Intelligence Wire September 28, 2010 700+ words
MorphoSys strengthens patent position on its core HuCAL technology in Europe.
News wire article from: Chemical Business Newsbase March 13, 2009 700+ words
MorphoSys Strengthens Patent Position on its Core HuCAL Technology in Europe.
News wire article from: Europe Intelligence Wire March 13, 2009 700+ words
MorphoSys Strengthens Patent Position on its Core Technologies in Japan.
News wire article from: Europe Intelligence Wire June 18, 2009 700+ words
Affitech strengthens patent position on its phagemid antibody screening...
News wire article from: Chemical Business Newsbase April 2, 2009 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily